Financial Controller
About the job
- At least 2–5 years of experience as a Controller.
- A bachelor's degree in Accounting is required.
- A solid understanding of generally accepted accounting principles (GAAP) and accounting process management is required.
- Proficiency with QuickBooks Online is required.
- Strong analytical skills and attention to detail are required.
- Experience with financial reporting, including profit and loss statements, balance sheets, and statements of cash flows, is required.
- Willingness and ability to work US business hours are required.
- Experience with due diligence or audit processes is a plus.
- Manage and supervise bookkeeping staff and oversee the division of duties.
- Take full responsibility for accounts receivable and accounts payable management across multiple client accounts.
- Ensure a comprehensive month-end close, including booking transactions, making adjusting journal entries, and preparing financial statements for review.
- Maintain proficiency in and day-to-day use of Ramp and QuickBooks Online.
- Provide reliable financial data for forecasting and support the fractional CFO with financial modeling, mainly in Excel, and data entry when needed.
- Review and correct financials prior to CFO review, minimizing the need for additional adjustments.
- Participate in special projects as needed, including due diligence for fundraising or acquisition, and preparation for audits.
- Communicate with team members and clients, working collaboratively and independently.
- Ramp experience is preferred but not required.
- Experience with due diligence or audit processes is a plus.
About the company
AgenT Biotech develops a platform for early cancer detection that combines advanced biosensors with artificial intelligence to identify cancer biomarkers quickly and accurately. The system collects biological signals with biosensors and uses AI to analyze complex data, spotting patterns that indicate cancer at an early stage. The product is designed to be more accurate and faster than current methods, enabling earlier treatment decisions. The company differentiates itself by integrating biosensing technology with AI in a single platform, which can be commercialized through partnerships with healthcare providers, licensing, or selling diagnostic kits. The goal is to improve patient outcomes by enabling earlier and more effective cancer treatment and, potentially, reduce healthcare costs through earlier intervention.
Company Size
11-50
Company Stage
N/A
Total Funding
$3M
Headquarters
Paris, France
Founded
2018
Get referred to Agent
See people who can refer or advise you
Simplify's Take
What believers are saying
- AgenT won Janssen Digital Solutions QuickFire Challenge recognition in 2026.
- Clinical studies remain ongoing, with retrospective sample analysis already underway.
- The company keeps adding partnerships, including INOVIE and academic medical centers.
What critics are saying
- AgenT shows zero disclosed venture funding beyond a €10,000 support program.
- No approved product exists; revenue depends entirely on successful clinical validation.
- The company’s Alzheimer’s focus diverges from the cancer-detection pitch, signaling market confusion.
What makes Agent unique
- AgenT combines multiomics biomarkers and machine learning for Alzheimer’s blood tests.
- The APOLLO program spans 4,200 retrospective samples across 20 cohorts.
- INOVIE partnership transfers proprietary quantification methods into a centralized clinical lab.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Remote Work Options